Novo Nordisk up 3% after FDA sends warning letters to 30 GLP-1 telehealth firms

Investing.com Gold reports: Novo Nordisk up 3% after FDA sends warning letters to 30 GLP-1 telehealth firms. This is a premium/paywalled source, so the brief is based on headline and available metadata only.